Robert Colgrove

Robert Colgrove


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2022 in Current Infectious Disease Reports
Verified
Journal Article
Closed access
PDF file
CJChinmay T. Jani
Chinmay T. Jani
Loukas KakoullisLoukas Kakoullis
Loukas Kakoullis
NANour Abdallah
Nour Abdallah
CMChristian F Mouchati
Christian F Mouchati
SPStephanie Page
Stephanie Page
LCLin Chen
Lin Chen

4 December 2025 in Clinical Infectious Diseases
Verified
Journal Article
Closed access
MKMichael Klompas
Michael Klompas
Majdi Al-HasanMajdi Al-Hasan
Majdi Al-Hasan
MMMayar Al Mohajer
Mayar Al Mohajer
RCRobert Colgrove
Robert Colgrove
SDShira Doron
Shira Doron
SWSharon Weissman
Sharon Weissman
The American Thoracic Society recently released updated community-acquired pneumonia (CAP) guidelines. The Infectious Diseases Society of America (IDSA) agreed with 8 of the 10 recommendations in the guidelines but declined to endorse the guidelines because they include recommendations for use of antibiotics in outpatients with comorbidities and inpatients with nonsevere CAP who test positive for respiratory viruses. It is noted in the guidelines that bacterial coinfections are common and that delaying antibiotics may be harmful. IDSA notes, however, that nondiscriminatory use of antibiotics for patients with CAP and positive viral assays confers more risks than benefits. Most patients do not have bacterial coinfections, and briefly withholding antibiotics for patients with nonsevere illness to clarify the diagnosis is safe. In this era of precision medicine, IDSA instead recommends individualized, dynamic decision-making that takes into account each patient´s evolving trajectory, severity of illness and balance of clinical features for and against coinfection.

14 December 2022 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
RCRobert Colgrove
Robert Colgrove
LBLou Ann Bruno-Murtha
Lou Ann Bruno-Murtha
CCCody A Chastain
Cody A Chastain
KHKimberly E Hanson
Kimberly E Hanson
FLFrancesca Lee
Francesca Lee
RHRomney Humphries
Romney Humphries
Diagnosis of acute severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection relies on detection of viral antigens or amplified viral nucleic acids. Serology, although invaluable for epidemiology, is not routinely needed clinically. However, in some settings, serologic data may have direct clinical utility: for example, in evaluation of persistent symptoms in patients without a prior diagnosis of acute infection. In contrast, SARS-CoV-2 serologic testing is sometimes used or requested in situations in which existing data do not support it, such as determination of need for vaccination. In this study, we describe available methods of serologic testing and provide cases supported by clinical vignettes of where such tests can be helpful, as well as examples where they are not. These examples may help clarify clinical decision making in this rapidly evolving area.

5 January 2022 in IJID Regions
Verified
Journal Article
Open access
JHJorge A. Huete-Pérez
Jorge A. Huete-Pérez
RCRobert Colgrove
Robert Colgrove
CCCristiana Cabezas-Robelo
Cristiana Cabezas-Robelo
LPLucía Páiz-Medina
Lucía Páiz-Medina
BHBhanasut Hunsajarupan
Bhanasut Hunsajarupan
AHAlejandra Huete
Alejandra Huete
To assess the prevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in selected health clinics in the three largest urban areas in Nicaragua, where data regarding coronavirus disease 2019 (COVID-19) testing, morbidity and mortality is severely limited. In this cross-sectional study, participants were tested for SARS-CoV-2 RNA by loop-mediated isothermal amplification (LAMP), and were tested for antibodies using immunoassays. A questionnaire recorded subjects’ COVID-19-associated symptoms and risk factors. Data were collected from 22 February to 19 March 2021, 1 year after the first confirmed cases of SARS-CoV-2 in Nicaragua. Study participants were enrolled while attending routine check-ups or seeking care unrelated to COVID-19. Study participation was random and voluntary. All patients were eligible to participate. Symptom history was not part of the eligibility criteria. The prevalence of current SARS-CoV-2 infection was high (14%, LAMP-positive/seronegative). Antibody testing showed higher overall seroprevalence (38%). Cough was the symptom most strongly associated with being LAMP-positive (odds ratio 3.57, 95% confidence interval 2.65–4.81). Loss of smell had the highest positive predictive value, and was significantly associated with being LAMP-positive. The prevalence of current SARS-CoV-2 infection and seropositivity were fairly high. More than half of the sample population had evidence of current or past infection. Knowledge of this previously unknown elevated level of infection is crucial for healthcare providers and policy makers.

6 March 2023 in Antimicrobial Stewardship & Healthcare Epidemiology
Verified
Journal Article
Open access
PDF file
DPDana E. Pepe
Dana E. Pepe
PMPreeti Mehrotra
Preeti Mehrotra
LBLou Ann Bruno-Murtha
Lou Ann Bruno-Murtha
RCRobert Colgrove
Robert Colgrove
SDShira Doron
Shira Doron
SWSharon B. Wright
Sharon B. Wright
The coronavirus disease 2019 (COVID-19) pandemic highlighted the lack of agreement regarding the definition of aerosol-generating procedures and potential risk to healthcare personnel. We convened a group of Massachusetts healthcare epidemiologists to develop consensus through expert opinion in an area where broader guidance was lacking at the time.

Verified
Journal Article
Open access
PDF file
Loukas KakoullisLoukas Kakoullis
Loukas Kakoullis
CHClaudia Hentschel
Claudia Hentschel
RCRobert Colgrove
Robert Colgrove
Background: We describe a case of EBV aseptic meningitis in a patient with HIV with an extensive history of prior infections and exposures. Detailed Case Description: A 35-year-old man with a history of HIV, syphilis, and partially treated tuberculosis presented with headache, fever, and myalgias. He reported recent exposure to dust from a construction site and had sexual contact with a partner with active genital lesions. An initial workup revealed mildly elevated inflammatory markers, significant pulmonary scarring from tuberculosis with a classic “weeping willow sign”, and lumbar puncture findings consistent with aseptic meningitis. An extensive evaluation was conducted to identify causes of bacterial and viral meningitis, including syphilis. Immune reconstitution inflammatory syndrome and isoniazid-induced aseptic meningitis were also considered based on his medications. EBV was ultimately isolated through PCR from the patient’s peripheral blood. The patient’s condition improved, and he was discharged on his home antiretroviral and anti-tuberculous treatment. Conclusion: Central nervous system infections represent unique challenges in patients with HIV. EBV reactivation can present with atypical symptoms and should be considered as a cause of aseptic meningitis in this population.